South Carolina’s full Senate has approved a rewritten version of House Bill 3924 on a 35 to 4 vote. The legislation would allow hemp beverages containing up to 5 milligrams of THC to be sold in ...
New research published in Free Radical Biology and Medicine found that cannabigerol (CBG) may have strong anti-cancer effects against pancreatic cancer cells, with researchers saying the compound ...
Centers for Medicare & Medicaid Services Releases New Details on CBD Pilot Program, Starting April 1
The Centers for Medicare and Medicaid Services has posted new details about its forthcoming hemp products pilot, confirming that certain Medicare beneficiaries may receive eligible hemp-derived ...
Colorado brought in nearly $20 million in marijuana tax revenue in January, and the state recorded over $1.31 billion in ...
A campaign to place medical marijuana legalization before Idaho voters in November has now collected more than 73,000 ...
A Vermont bill that would expand marijuana purchase and possession limits while allowing cannabis events and deliveries has advanced further in the legislature and is now headed to the full Senate.
Maryland’s Senate Bill 54, which would protect veterinarians from professional discipline solely for discussing or ...
A bipartisan bill filed yesterday in the New York Assembly would require annual audits of the Office of Cannabis Management, adding a new layer of oversight to the agency responsible for regulating ...
A New York bill that would recognize out-of-state medical marijuana patients and require regulators to approve pre-roll products in the state’s medical program has now cleared another hurdle in the ...
A randomized clinical trial published in Cannabis and Cannabinoid Research found that regular aerobic exercise may significantly reduce migraine frequency while also altering levels of anandamide, a ...
A study published today in Neuroscience by researchers from the Russian Academy of Sciences finds that cannabinoid-based ...
The Oklahoma Medical Marijuana Authority has issued a mandatory recall for medical marijuana products tested by Greenleaf Labs between April 2023 and July 2025, escalating an issue the agency says has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results